These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7163495)

  • 1. Imbalance of brain monoamines and clinical disorders.
    Hornykiewicz O
    Prog Brain Res; 1982; 55():419-29. PubMed ID: 7163495
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of methiothepin on cerebral monoamine neurons.
    Lloyd KG; Bartholini G
    Adv Biochem Psychopharmacol; 1974; 10():305-9. PubMed ID: 4846546
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Turnover of biogenic amines after acute and chronic morphine treatment in rats.
    Theiss P; Papeschi R
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R98. PubMed ID: 4276659
    [No Abstract]   [Full Text] [Related]  

  • 5. [Convulsions and monoamines].
    Kariya T
    Nihon Rinsho; 1978; 36(1):90-4. PubMed ID: 633637
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modifications of cerebral amine metabolism in psychiatric illness].
    Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1980; 80(5):559-73. PubMed ID: 6165224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of catalepsy and depletion of brain monoamines by a butyrophenone derivative.
    Fuenmayor LD; Vogt M
    Br J Pharmacol; 1979 Sep; 67(1):115-22. PubMed ID: 574039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relevance of dopamine agonists in the treatment of depression].
    Clausius N; Born C; Grunze H
    Neuropsychiatr; 2009; 23(1):15-25. PubMed ID: 19272288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
    Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
    Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biogenic amines in the pathogenesis of different forms of viral infections].
    Popenenkova ZA; Maslennikov GA
    Vestn Akad Med Nauk SSSR; 1977; (7):83-92. PubMed ID: 197741
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732
    [No Abstract]   [Full Text] [Related]  

  • 13. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of brain dopamine sulfate levels in relation to free dopamine and homovanillic acid in Parkinson's disease.
    Sofic E; Riederer P; Wesemann W; Kienzl E; Eichinger K; Gsell W; Jellinger K
    J Neural Transm Park Dis Dement Sect; 1991; 3(4):265-71. PubMed ID: 1772579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamines and neurologic diseases (second of two parts).
    Moskowitz MA; Wurtman RJ
    N Engl J Med; 1975 Aug; 293(7):332-8. PubMed ID: 125386
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonergic-dopaminergic interactions and extrapyramidal function.
    Chase TN
    Adv Biochem Psychopharmacol; 1974; 11(0):377-85. PubMed ID: 4367649
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of the dopaminergic lesion in Parkinson's disease by CSF markers.
    LeWitt PA
    Adv Neurol; 1993; 60():544-7. PubMed ID: 8420188
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroendocrine aspects of the relief of melancholia by induced seizures (electroconvulsive treatment).
    Fink M
    Adv Biochem Psychopharmacol; 1984; 39():345-57. PubMed ID: 6205561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resiliency of monoaminergic systems: the 80% rule and its relevance to drug development.
    Blier P
    J Psychopharmacol; 2008 Aug; 22(6):587-9. PubMed ID: 18753271
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent views on tremors and their treatment.
    Poirier LJ
    Mod Trends Neurol; 1970; 5(0):80-95. PubMed ID: 4369120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.